Patents Assigned to SOLYPLUS GMBH
  • Patent number: 12138310
    Abstract: The invention relates primarily to a processing method of biopolymers by means of solvent/solvent mixtures or multiphase solvent systems by means of which said polymers can be changed in their mechanical and qualitative features and processed more easily.
    Type: Grant
    Filed: October 9, 2018
    Date of Patent: November 12, 2024
    Assignee: SolyPlus GmbH
    Inventors: Richard Dolph Andersen, Annette Assogba-Zandt, Elena Maltseva, Andreas Voigt
  • Publication number: 20240050366
    Abstract: Compounds and compositions, their use and methods using the compounds and compositions for preventing an infection, e.g. an infection by a virus or bacterium, or treating an infection, e.g. a virus or bacterial infection, or treating a disease caused by an infection, e.g. a virus or bacterial infection, and a method of increasing the binding of virus neutralizing antibodies, an in vitro method of detecting virus-specific antibodies in a sample obtained from a subject, a compound for use in a method of detecting of virus-specific antibodies in a subject, and a kit for the detection of virus-specific antibodies.
    Type: Application
    Filed: October 21, 2021
    Publication date: February 15, 2024
    Applicants: SOLYPLUS GMBH, LEOPOLD GMBH
    Inventors: Andreas VOIGT, Richard Dolph ANDERSEN, Karl SKRINER, Joachim BENDER
  • Publication number: 20230346824
    Abstract: A composition for use in preventing an infection, or treating an infection, or treating a disease caused by an infection, the composition including a compound selected from the group of chitosan or a salt thereof, galactose, mannose, caffeine, and any combination thereof.
    Type: Application
    Filed: April 14, 2021
    Publication date: November 2, 2023
    Applicants: SolyPlus GmbH, Leopold GmbH
    Inventors: Andreas VOIGT, Richard Dolph ANDERSEN, Karl SKRINER
  • Patent number: 11248094
    Abstract: The present invention relates to methods of providing biocompatible/biodegradable hydrogels obtained by crosslinking of biopolymers (for example polysaccharides or proteins) in the semi-solid (modelling-clay like) state at water content below 70% by weight. The resulting materials can be applied in medicine, pharmacy and/or in cosmetics.
    Type: Grant
    Filed: October 9, 2018
    Date of Patent: February 15, 2022
    Assignee: SOLYPLUS GMBH
    Inventors: Richard Dolph Andersen, Annette Assogba-Zandt, Elena Maltseva, Andreas Voigt